Web24 Mar 2024 · Oslo, 24 March 2024: Ultimovacs ASA (“Ultimovacs”, ticker ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announces that … Web14 Apr 2024 · Oslo, 14 April 2024: In connection with the Annual General Meeting of Ultimovacs ASA to be held on 20 April 2024, Jónas Einarsson, Chair of the Board of Directors, has so far received proxy based voting rights without voting instructions for 11,364,278 shares, representing 33.04% of the total voting rights in the company. With the …
Investors - Ultimovacs
Web"Producer Scott Ferguson and his team studied different countries but realized Norway had "an exceptional landscape like nowhere else in the world." He tells… WebA conceptual model of patient #prioritization #pharmaceutical #acuity_report_FINALv6[73] B (eahp.eu) #pharmaceuticalcare pelican pass pass christian ms
Ultimovacs Announces Acceptance of Publication in ‘Frontiers in ...
Web16 Feb 2024 · Ultimovacs is a clinical-stage biotech company developing novel immunotherapies against cancer. Lead product, UV1, is a cancer vaccine aiming to … Web4 Jun 2024 · UV1/pembrolizumab results in 30% complete responses plus 30% partial responsesGood safety and tolerability profile supports expanded Phase II combination … Web13 Apr 2024 · Ultimovacs Receives Intention to Grant Notice on European Patent on UV1 Cancer Vaccine … 13th April 2024 Corresponding patent granted in the US, additional … pelican parts porsche 911 sc talbot yellow